Beth Israel Med Ctr — New York, New York

Beth Israel Med Ctr is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Beth Israel Med Ctr has participated in 74 clinical trials with 1 currently active.

Therapeutic areas: Mycobacterium Avium-intracellulare Infection, HIV Infections, Cytomegalovirus Infections.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Hoffmann-La Roche, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Med Ctr?

Beth Israel Med Ctr has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Med Ctr conducted?

Beth Israel Med Ctr has 74 clinical trials on record, with 1 currently active. Their work covers Mycobacterium Avium-intracellulare Infection, HIV Infections, Cytomegalovirus Infections.

Is Beth Israel Med Ctr accredited by Crixeo Health?

Yes — Beth Israel Med Ctr holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Beth Israel Med Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.